RSV vaccine uptake will start slower than shingles shot: GSK CEO
By A Mystery Man Writer
Description
S-1
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales - WSJ
SEC Filing
GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO
GSK
What will it take to make an effective vaccine for COVID-19?
CNBC Transcript: GSK CEO Emma Walmsley Speaks with CNBC's Jim Cramer Live During CNBC's Healthy Returns Summit Today - CNBC Events
GSK expects RSV vaccine uptake will be slower than shingles vaccine
SEC Filing
COVID Vaccine Tracker
GSK Boosts Profit Forecasts After 'Outstanding' RSV Vaccine Launch
What will it take to make an effective vaccine for COVID-19?
from
per adult (price varies by group size)